Last Price
16.76
Today's Change
-0.61 (3.51%)
Day's Change
16.41 - 17.46
Trading Volume
4,609,908
Profile
AUP
Exchange: Toronto Stock Exchange Toronto Stock Exchange
Currency: CAD CAD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Peter Greenleaf Mr. Peter Greenleaf
Full Time Employees: 294 294
IPO Date: 2000-09-19 2000-09-19
Description
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops and commercializes therapies to treat various diseases in the United States and China. It is involved in developing voclosporin, an investigational drug for the treatment of lupus nephritis, dry eye syndrome, and focal segmental glomerulosclerosis. The company is headquartered in Victoria, Canada.
Address
1203-4464 Markham St,
Victoria, BRITISH COLUMBIA V8Z 7X8, CA
12507084272
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
War World 3?
Poll Closed Upcoming PollIs WW3 coming?
Select only one answer
Yes, we are very close to it!
1 vote(s)
50.00%
No, we are not there yet!
0 vote(s)
0%
Possible a regional war - not full scale WW3
1 vote(s)
50.00%
1713671999000
Top Articles
1
CEO Morning Brief
Canada Hikes Capital Gains Tax to Raise Billions for Housing
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
